Phase II trial of zeniplatin (CL 286 558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy

Maurie Markman, Linda C. DeMarco, Martin Birkhofer, Daniel Budman, Thomas Hakes, Bonnie Reichman, Stephen Rubin, Walter Jones, Richard Barakat, John Curtin, John L. Lewis, Lois Almadrones, Arlene Hoffman, Ram Rastogi, William Hoskins

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of zeniplatin (CL 286 558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science